Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication

Stroke

Volumn 47, Issue 6, 2016, Pages 1500-1507

  Myint, Phyo Kyaw ^a   Kwok, Chun Shing ^b   Roffe, Christine ^b   Kontopantelis, Evangelos ^c   Zaman, Azfar ^d   Berry, Colin ^e   Ludman, Peter F ^f   De Belder, Mark A ^g   Mamas, Mamas A ^b,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e ROYAL JUBILEE HOSPITAL   (Canada)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^g JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

elective percutaneous coronary intervention; mortality; nonelective percutaneous coronary intervention; prognosis; risk factor; stroke

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK FACTOR; TREATMENT INDICATION; CARDIOVASCULAR DISEASE; COMPLICATION; FACTUAL DATABASE; HOSPITAL MORTALITY; MIDDLE AGED; SMOKING; STROKE; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY;

ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RISK FACTORS; SMOKING; STROKE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84966698773     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.012700     Document Type: Article

References (16)

1. Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT; American College of Cardiology National Cardiovascular Data Registry. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009;104:349-353. doi: 10.1016/j.amjcard.2009.03.046.
2. Werner N, Bauer T, Hochadel M, Zahn R, Weidinger F, Marco J, et al. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the Euro Heart Survey Percutaneous Coronary Interventions Registry. Circ Cardiovasc Interv. 2013;6:362-369. doi: 10.1161/CIRCINTERVENTIONS.112.000170.
3. Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, et al. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013;6:176-183. doi: 10.1161/CIRCINTERVENTIONS.112.000159.
4. Kwok CS, Kontopantelis E, Myint PK, Zaman A, Berry C, Keavney B, et al; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research. Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12. Eur Heart J. 2015;36:1618-1628. doi: 10.1093/eurheartj/ehv113.
5. Hoffman SJ, Routledge HC, Lennon RJ, Mustafa MZ, Rihal CS, Gersh BJ, et al. Procedural factors associated with percutaneous coronary intervention-related ischemic stroke. JACC Cardiovasc Interv. 2012;5:200-206. doi: 10.1016/j.jcin.2011.10.014.
6. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399-415. doi: 10.1038/nrn1106.
7. Duffis EJ, Jones D, Tighe D, Moonis M. Neurological complications of coronary angiographic procedures. Expert Rev Cardiovasc Ther. 2007;5:1113-1121. doi: 10.1586/14779072.5.6.1113.
8. Singh M, Rihal CS, Gersh BJ, Lennon RJ, Prasad A, Sorajja P, et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007;115:2835-2841. doi: 10.1161/CIRCULATIONAHA.106.632679.
9. Hoffman SJ, Holmes DR Jr, Rabinstein AA, Rihal CS, Gersh BJ, Lennon RJ, et al. Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience. JACC Cardiovasc Interv. 2011;4:415-422. doi: 10.1016/j.jcin.2010.11.010.
10. Chong E, Poh KK, Liang S, Soon CY, Tan HC. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol. 2010;23:451-459. doi: 10.1111/j.1540-8183.2010.00581.x.
11. Merchant FM, Weiner RB, Rao SR, Lawrence R, Healy JL, Pomerantsev E, et al. In-hospital outcomes of emergent and elective percutaneous coronary intervention in octogenarians. Coron Artery Dis. 2009;20:118-123. doi: 10.1097/MCA.0b013e3283292ae1.
12. Kwok CS, Skinner J, Metcalf AK, Potter JF, Myint PK. Prior antiplatelet or anticoagulant therapy and mortality in stroke. Heart. 2012;98:712-717. doi: 10.1136/heartjnl-2011-301076.
13. EPISTENT Investigators. Randomised placebo-controlled and balloonangioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998;352:87-92. doi: 10.1016/S0140-6736(98)85010-1.
14. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961. doi: 10.1056/NEJM199404073301402.
15. Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, et al; TOTAL Investigators. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372:1389-1398. doi: 10.1056/NEJMoa1415098.
16. SCAAR Annual Report 2011. Scand Cardiovasc J. 2013;47(suppl 62):55-76. doi: 10.3109/14017431.2013.779835.